Light, Nanomaterials and Nanotechnology (L2n) Laboratory, CNRS EMR 7004, University of Technology of Troyes, 12 Rue Marie Curie, CS 42060, CEDEX, 10004 Troyes, France.
Int J Mol Sci. 2023 May 25;24(11):9249. doi: 10.3390/ijms24119249.
Since the outbreak of the pandemic respiratory virus SARS-CoV-2 (COVID-19), academic communities and governments/private companies have used several detection techniques based on gold nanoparticles (AuNPs). In this emergency context, colloidal AuNPs are highly valuable easy-to-synthesize biocompatible materials that can be used for different functionalization strategies and rapid viral immunodiagnosis. In this review, the latest multidisciplinary developments in the bioconjugation of AuNPs for the detection of SARS-CoV-2 virus and its proteins in (spiked) real samples are discussed for the first time, with reference to the optimal parameters provided by three approaches: one theoretical, via computational prediction, and two experimental, using dry and wet chemistry based on single/multistep protocols. Overall, to achieve high specificity and low detection limits for the target viral biomolecules, optimal running buffers for bioreagent dilutions and nanostructure washes should be validated before conducting optical, electrochemical, and acoustic biosensing investigations. Indeed, there is plenty of room for improvement in using gold nanomaterials as stable platforms for ultrasensitive and simultaneous "in vitro" detection by the untrained public of the whole SARS-CoV-2 virus, its proteins, and specific developed IgA/IgM/IgG antibodies (Ab) in bodily fluids. Hence, the lateral flow assay (LFA) approach is a quick and judicious solution to combating the pandemic. In this context, the author classifies LFAs according to four generations to guide readers in the future development of multifunctional biosensing platforms. Undoubtedly, the LFA kit market will continue to improve, adapting researchers' multidetection platforms for smartphones with easy-to-analyze results, and establishing user-friendly tools for more effective preventive and medical treatments.
自大流行呼吸道病毒 SARS-CoV-2(COVID-19)爆发以来,学术团体和政府/私营公司已经使用了几种基于金纳米粒子(AuNPs)的检测技术。在这种紧急情况下,胶体 AuNPs 是非常有价值的易于合成的生物相容性材料,可用于不同的功能化策略和快速病毒免疫诊断。在这篇综述中,首次讨论了用于检测 SARS-CoV-2 病毒及其在(加标)实际样品中蛋白质的 AuNP 生物偶联的最新多学科进展,参考了三种方法提供的最佳参数:一种是理论上的,通过计算预测,另外两种是实验上的,使用基于单步/多步方案的干法和湿法化学。总体而言,为了实现对目标病毒生物分子的高特异性和低检测限,在进行光学、电化学和声学生物传感研究之前,应验证用于生物试剂稀释和纳米结构洗涤的最佳运行缓冲液。事实上,使用金纳米材料作为稳定平台,用于未经训练的公众对整个 SARS-CoV-2 病毒、其蛋白质以及特定开发的体液中的 IgA/IgM/IgG 抗体(Ab)进行超灵敏和同时“体外”检测,还有很大的改进空间。因此,侧向流动分析(LFA)方法是应对大流行的快速而明智的解决方案。在这种情况下,作者根据四代人对 LFAs 进行分类,以指导读者在未来开发多功能生物传感平台。毫无疑问,LFA 试剂盒市场将继续改进,使研究人员能够将其多检测平台适应带有易于分析结果的智能手机,并为更有效的预防和医疗治疗建立用户友好的工具。